NMCAX
Price
$19.81
Change
+$0.27 (+1.38%)
Updated
Jul 25 closing price
Net Assets
738.08M
RRMGX
Price
$90.44
Change
+$0.46 (+0.51%)
Updated
Jul 25 closing price
Net Assets
27.99B
Interact to see
Advertisement

NMCAX vs RRMGX

Header iconNMCAX vs RRMGX Comparison
Open Charts NMCAX vs RRMGXBanner chart's image
Voya MidCap Opportunities A
Price$19.81
Change+$0.27 (+1.38%)
VolumeN/A
Net Assets738.08M
T. Rowe Price Mid-Cap Growth R
Price$90.44
Change+$0.46 (+0.51%)
VolumeN/A
Net Assets27.99B
NMCAX vs RRMGX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
NMCAX vs. RRMGX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NMCAX is a Buy and RRMGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RRMGX has more cash in the bank: 28B vs. NMCAX (738M). NMCAX (0.00) and RRMGX (0.00) have matching dividends . NMCAX was incepted earlier than RRMGX: NMCAX (27 years) vs RRMGX (23 years). RRMGX (1.29) and NMCAX (1.25) have similar cost to investors . NMCAX is a more actively managed with annual turnover of: 70.00 vs. RRMGX (22.60). NMCAX has a lower initial minimum investment than RRMGX: NMCAX (1000) vs RRMGX (2500). NMCAX annual gain was more profitable for investors over the last year : 7.66 vs. RRMGX (-2.69). RRMGX return over 5 years is better than : 0.33 vs. NMCAX (-8.75).
NMCAXRRMGXNMCAX / RRMGX
Total Expense Ratio1.251.2997%
Annual Report Gross Expense Ratio1.251.2997%
Fund Existence27 years23 years-
Gain YTD8.7862.866307%
Front Load6%N/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets738M28B3%
Annual Yield % from dividends0.000.00-
Returns for 1 year7.66-2.69-285%
Returns for 3 years37.479.07413%
Returns for 5 years-8.750.33-2,630%
Returns for 10 years-16.5216.67-99%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OBIO3.290.07
+2.17%
Orchestra BioMed Holdings
VSEC136.672.59
+1.93%
VSE Corp
BBY67.29N/A
N/A
Best Buy Company
SEGG1.12-0.04
-3.45%
Lottery com Inc
ZBIO15.66-0.66
-4.04%
Zenas Biopharma Inc.